Dare Bioscience, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $4.46K.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $120.15K.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $1.00.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $124.60K, a 283.06% increase from fiscal 2021.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $32.53K, a 3252800.00% increase from fiscal 2020.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $1.00.
- Dare Bioscience, Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $1.63M, a 1062.86% increase from fiscal 2014.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-12-31 | $124.60K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $4.46K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $120.15K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $32.53K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.00 10-K · filed 2022-03-31 | |
| 2020-03-31 | $1.00 10-Q · filed 2021-11-10 | |
| 2015-12-31 | $1.63M 10-K/A · filed 2017-06-13 | |
| 2014-12-31 | $140.00K 10-K/A · filed 2017-06-13 | |
| 2013-12-31 | $35.00K 10-K · filed 2016-03-10 | |
| 2012-12-31 | $3.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |